Congress·In Committee·S. 882

Senate Bill Would Overhaul Medicare Drug Middlemen, Require Full Rebate Pass-Through to Patients

Patients Before Middlemen Act

about 1 year ago·View on Congress.gov

Part of: Pharmacy Benefit Manager (PBM) Reform

⏸

Stalled

No legislative action in over 90 days.

Legislative Progress

Senate

House

President

Law

Key Points

This bill aims to lower costs and increase pharmacy choices for people on Medicare by changing how 'middlemen,' known as pharmacy benefit managers, are allowed to make money. It requires these companies to be paid flat fees for their services rather than taking a percentage of high drug prices.
The policy would require Medicare drug plans to allow any pharmacy to join their network as long as the pharmacy agrees to standard contract terms. This is designed to help independent and local drugstores stay in business and ensure seniors don't have to travel long distances to get their prescriptions.
Starting in 2028, drug middlemen would be forced to pass 100% of the rebates and discounts they get from drug makers directly to the insurance plans. This prevents these companies from keeping secret profits that could otherwise be used to lower premiums or out-of-pocket costs for patients.
The bill creates special protections for 'essential' pharmacies in rural or underserved areas. The government would track how much these local shops are being paid compared to large mail-order pharmacies owned by the insurance companies to ensure fair treatment.
To ensure honesty, the bill gives insurance plans the right to audit their drug middlemen at least once a year. It also allows pharmacies to report unfair contracts to the government without fear of being punished or kicked out of the network.
If a drug middleman breaks these rules, they could face expensive government fines. Any illegal profits they made would have to be paid back to the Medicare drug plan.

HealthcareEconomy Finance

Impact Analysis

Personal Impact

Who is affectedScoreImpactCertaintyScopeDurationSentiment

Scores: 1 = low, 5 = highSentiment: -5 to +5 (net benefit)

Political Response

Milestones

2 milestones2 actions

Mar 6, 2025Senate

Read twice and referred to the Committee on Finance.

Mar 6, 2025

Introduced in Senate

What Happens Next

Projected impacts based on AI analysis

2026-04-01

HHS issues a public request for information on pharmacy contract practices

The government starts gathering input from pharmacies, insurers, and the public about how drug plan contracts currently work. This is the first step toward setting fair contract standards.

Spring 2027

HHS publishes standards for fair pharmacy contracts and standard reporting formats

The government finalizes the rules that drug plans must follow when contracting with pharmacies, and sets up how PBMs must report their financial data. This sets the stage for the major changes taking effect the following year.

2028-01-01

All major provisions take effect for the 2028 plan year

Starting January 1, 2028, any pharmacy can join a Medicare drug plan network, PBMs must limit their income to flat service fees, drug plans must publish detailed cost and rebate reports, and pharmacies gain the right to report unfair treatment to the government. Medicare beneficiaries should see more pharmacy choices and potentially lower costs.

Related News

4 articles

Healthcare Brew·26 days ago

What new PBM reforms mean for pharma

The Consolidated Appropriations Act of 2026 introduces new regulations for PBMs, including delinking compensation in Medicare Part D from drug list prices and requiring 'reasonable and relevant' contracts for all pharmacies. Starting in 2028, PBMs must pass through 100% of manufacturer rebates.

Pharmacy Times·about 2 months ago

PBM Reform Within 2026 Appropriations Bill Signed Into Law

President Trump signed the Consolidated Appropriations Act of 2026 on Feb. 3, codifying key PBM reforms. The law restricts Part D remuneration to flat-dollar service fees starting in 2028 and mandates 100% pass-through of rebates to employer plans while strengthening pharmacy network protections.

C+

AJMC·about 1 month ago

PBM Reforms, Restoration of Science Cuts Seen in $1.2T Spending Deal for 2026

The $1.2 trillion spending package passed in February 2026 includes a package of reforms for pharmacy benefit managers. These provisions prohibit price-linked remuneration in Medicare Part D, require 100% rebate pass-through, and ensure reasonable pharmacy network contracting standards.

Related Bills

3 bills

H.R. 7148Related bill

Consolidated Appropriations Act, 2026

Feb 3 — Became Public Law No: 119-75.

S. 891Related bill

Bipartisan Health Care Act

Mar 6 — Read twice and referred to the Committee on Finance.

H.R. 1768Related bill

Lower Costs for Everyday Americans Act

Mar 3 — Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, the Budget, the Judiciary, and Education and Workforce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.